Repare Therapeutics Inc (RPTX) — Cash Flow Reinvestment Rate
Repare Therapeutics Inc (RPTX) has a Cash Flow Reinvestment Rate of 0.96x as of September 2025, reinvesting $2.54 Million (capex $0.00 plus investments $2.54 Million) from operating cash flow of $2.65 Million. See Repare Therapeutics Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Repare Therapeutics Inc Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Repare Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Repare Therapeutics Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Repare Therapeutics Inc (2022–2022)
Year-by-year capital reinvestment analysis for Repare Therapeutics Inc. See Repare Therapeutics Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 547.76x | $176.38 Million | $322.00K | $602.00K | — |